Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Biochim Biophys Acta ; 1852(4): 651-7, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25486268

ABSTRACT

Disorders affecting the presynaptic, synaptic, and postsynaptic portions of the neuromuscular junction arise from various mechanisms in children and adults, including acquired autoimmune or toxic processes as well as genetic mutations. Disorders include autoimmune myasthenia gravis associated with acetylcholine receptor, muscle specific kinase or Lrp4 antibodies, Lambert-Eaton myasthenic syndrome, nerve terminal hyperexcitability syndromes, Guillain Barré syndrome, botulism, organophosphate poisoning and a number of congenital myasthenic syndromes. This review focuses on the various molecular and pathophysiological mechanisms of these disorders, characterization of which has been crucial to the development of treatment strategies specific for each pathogenic mechanism. In the future, further understanding of the underlying processes may lead to more effective and targeted therapies of these disorders. This article is part of a Special Issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis.


Subject(s)
Botulism , Guillain-Barre Syndrome , Lambert-Eaton Myasthenic Syndrome , Myasthenia Gravis , Organophosphate Poisoning , Adolescent , Adult , Autoantibodies/immunology , Autoantibodies/metabolism , Botulism/genetics , Botulism/immunology , Botulism/metabolism , Botulism/pathology , Child , Child, Preschool , Guillain-Barre Syndrome/genetics , Guillain-Barre Syndrome/immunology , Guillain-Barre Syndrome/metabolism , Guillain-Barre Syndrome/pathology , Humans , LDL-Receptor Related Proteins/genetics , LDL-Receptor Related Proteins/immunology , LDL-Receptor Related Proteins/metabolism , Lambert-Eaton Myasthenic Syndrome/genetics , Lambert-Eaton Myasthenic Syndrome/immunology , Lambert-Eaton Myasthenic Syndrome/metabolism , Lambert-Eaton Myasthenic Syndrome/pathology , Myasthenia Gravis/genetics , Myasthenia Gravis/immunology , Myasthenia Gravis/metabolism , Myasthenia Gravis/pathology , Neuromuscular Junction/genetics , Neuromuscular Junction/immunology , Neuromuscular Junction/metabolism , Neuromuscular Junction/pathology , Organophosphate Poisoning/genetics , Organophosphate Poisoning/immunology , Organophosphate Poisoning/metabolism , Organophosphate Poisoning/pathology , Receptors, Cholinergic/genetics , Receptors, Cholinergic/immunology , Receptors, Cholinergic/metabolism
2.
Inhal Toxicol ; 26(7): 371-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24766293

ABSTRACT

This study evaluated acute toxicity and pulmonary injury in rats at 3, 6 and 24 h after an inhalation exposure to aerosolized O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothioate (VX). Anesthetized male Sprague-Dawley rats (250-300 g) were incubated with a glass endotracheal tube and exposed to saline or VX (171, 343 and 514 mg×min/m³ or 0.2, 0.5 and 0.8 LCt50, respectively) for 10 min. VX was delivered by a small animal ventilator at a volume of 2.5 ml × 70 breaths/minute. All VX-exposed animals experienced a significant loss in percentage body weight at 3, 6, and 24 h post-exposure. In comparison to controls, animals exposed to 514 mg×min/m³ of VX had significant increases in bronchoalveolar lavage (BAL) protein concentrations at 6 and 24 h post-exposure. Blood acetylcholinesterase (AChE) activity was inhibited dose dependently at each of the times points for all VX-exposed groups. AChE activity in lung homogenates was significantly inhibited in all VX-exposed groups at each time point. All VX-exposed animals assessed at 20 min and 3, 6 and 24 h post-exposure showed increases in lung resistance, which was prominent at 20 min and 3 h post-exposure. Histopathologic evaluation of lung tissue of the 514 mg×min/m³ VX-exposed animals at 3, 6 and 24 h indicated morphological changes, including perivascular inflammation, alveolar exudate and histiocytosis, alveolar septal inflammation and edema, alveolar epithelial necrosis, and bronchiolar inflammatory infiltrates, in comparison to controls. These results suggest that aerosolization of the highly toxic, persistent chemical warfare nerve agent VX results in acute pulmonary toxicity and lung injury in rats.


Subject(s)
Chemical Warfare Agents/toxicity , Inhalation Exposure/adverse effects , Lung/drug effects , Organophosphate Poisoning/physiopathology , Organothiophosphorus Compounds/toxicity , Respiratory Mucosa/drug effects , Trachea/drug effects , Acetylcholinesterase/blood , Acetylcholinesterase/chemistry , Acetylcholinesterase/metabolism , Aerosols , Airway Resistance , Animals , Bronchoalveolar Lavage Fluid/chemistry , Cholinesterase Inhibitors/toxicity , Dose-Response Relationship, Drug , Lung/immunology , Lung/metabolism , Lung/pathology , Male , Necrosis , Organophosphate Poisoning/enzymology , Organophosphate Poisoning/immunology , Organophosphate Poisoning/pathology , Pneumonia/chemically induced , Pulmonary Edema/chemically induced , Rats, Sprague-Dawley , Respiratory Mucosa/immunology , Respiratory Mucosa/metabolism , Respiratory Mucosa/pathology , Toxicokinetics , Trachea/immunology , Trachea/metabolism , Trachea/pathology , Ulcer/etiology , Weight Loss/drug effects
3.
Chem Biol Interact ; 206(3): 472-8, 2013 Dec 05.
Article in English | MEDLINE | ID: mdl-23994500

ABSTRACT

Organophosphourus compounds (OPC, including nerve agents and pesticides) exhibit acute toxicity by inhibition of acetylcholinesterase. Lung affections are frequent complications and a risk factor for death. In addition, epidemiological studies reported immunological alterations after OPC exposure. In our experiments we investigated the effects of organophosphourus pesticides dimethoate and chlorpyrifos on dendritic cells (DC) that are essential for the initial immune response, especially in the pulmonary system. DC, differentiated from the monocyte cell line THP-1 by using various cytokines (IL-4, GM-CSF, TNF-α, Ionomycin), were exposed to organophosphourus compounds at different concentrations for a 24h time period. DC were characterized by flow cytometry and immunofluorescence using typical dendritic cell markers (e.g., CD11c, CD209 and CD83). After OPC exposure we investigated cell death, the secretion profile of inflammatory mediators, changes of DC morphology, and the effect on protein kinase signalling pathways. Our results revealed a successful differentiation of THP-1 into DC. OPC exposure caused a significant concentration-dependent influence on DC: Dendrites of the DC were shortened and damaged, DC-specific cell surface markers (i.e., CD83and CD209) decreased dramatically after chlorpyrifos exposure. Interestingly, the effects caused by dimethoate were in general less pronounced. The organophosphourus compounds affected the release of inflammatory cytokines, such as IL-1ß and IL-8. The anti-inflammatory cytokine IL-10 was significantly down regulated. Protein kinases like the Akt family or ERK, which are essential for cell survival and proliferation, were inhibited by both OPC. These findings indicate that the tested organophosphourus compounds induced significant changes in cell morphology, inhibited anti-inflammatory cytokines and influenced important protein signalling pathways which are involved in regulation of apoptosis. Thus our results highlight novel aspects -apparently independent of AChE inhibition- of OPC poisoning with regard to lung toxicity. Our findings contribute to the basic understanding of pulmonary complications caused by OPC poisoning.


Subject(s)
Dendritic Cells/drug effects , Dendritic Cells/immunology , Organophosphate Poisoning/immunology , Cell Death/drug effects , Cell Differentiation/drug effects , Cell Line , Chlorpyrifos/toxicity , Cytokines/metabolism , Dendritic Cells/pathology , Dimethoate/toxicity , Humans , Insecticides/poisoning , MAP Kinase Signaling System/drug effects , Monocytes/drug effects , Monocytes/immunology , Organophosphate Poisoning/pathology , Pesticides/toxicity
5.
Proc Natl Acad Sci U S A ; 110(22): 8842-6, 2013 May 28.
Article in English | MEDLINE | ID: mdl-23630255

ABSTRACT

As a managed pollinator, the honey bee Apis mellifera is critical to the American agricultural enterprise. Recent colony losses have thus raised concerns; possible explanations for bee decline include nutritional deficiencies and exposures to pesticides and pathogens. We determined that constituents found in honey, including p-coumaric acid, pinocembrin, and pinobanksin 5-methyl ether, specifically induce detoxification genes. These inducers are primarily found not in nectar but in pollen in the case of p-coumaric acid (a monomer of sporopollenin, the principal constituent of pollen cell walls) and propolis, a resinous material gathered and processed by bees to line wax cells. RNA-seq analysis (massively parallel RNA sequencing) revealed that p-coumaric acid specifically up-regulates all classes of detoxification genes as well as select antimicrobial peptide genes. This up-regulation has functional significance in that that adding p-coumaric acid to a diet of sucrose increases midgut metabolism of coumaphos, a widely used in-hive acaricide, by ∼60%. As a major component of pollen grains, p-coumaric acid is ubiquitous in the natural diet of honey bees and may function as a nutraceutical regulating immune and detoxification processes. The widespread apicultural use of honey substitutes, including high-fructose corn syrup, may thus compromise the ability of honey bees to cope with pesticides and pathogens and contribute to colony losses.


Subject(s)
Bees/immunology , Colony Collapse/chemically induced , Coumaric Acids/pharmacology , Gene Expression Regulation/immunology , Honey/analysis , Inactivation, Metabolic/immunology , Organophosphate Poisoning/immunology , Animals , Antimicrobial Cationic Peptides/metabolism , Bees/genetics , Chromatography, High Pressure Liquid , Coumaphos/toxicity , Coumaric Acids/chemistry , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Flavanones/chemistry , Flavanones/pharmacology , Gene Expression Regulation/drug effects , High-Throughput Nucleotide Sequencing , Inactivation, Metabolic/genetics , Pollen/chemistry , Propionates , Propolis/chemistry , Real-Time Polymerase Chain Reaction , Tandem Mass Spectrometry
6.
Neurotox Res ; 24(2): 265-79, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23532600

ABSTRACT

Organophosphate (OP) poisoning is associated with long-lasting neurological damage, which is attributed mainly to the excessive levels of glutamate caused by the intoxication. Glutamate toxicity, however, is not specific to OP poisoning, and is linked to propagation of damage in both acute and chronic neurodegenerative conditions in the central nervous system (CNS). In addition to acute excitotoxic effects of glutamate, there is now a growing amount of evidence of its intricate immunomodulatory effects in the brain, involving both the innate and the adaptive immune systems. Moreover, it was demonstrated that immunomodulatory treatments, aimed at regulating the interaction between the resident immune cells of the brain (microglia) and the peripheral immune system, can support buffering of excessive levels of glutamate and restoration of the homeostasis. In this review, we will discuss the role of glutamate as an excitotoxic agent in the acute phase of OP poisoning, and the possible functions it may have as both a neuroprotectant and an immunomodulator in the sub-acute and chronic phases of OP poisoning. In addition, we will describe the novel immune-based neuroprotective strategies aimed at counteracting the long-term neurodegenerative effects of glutamate in the CNS.


Subject(s)
Adaptive Immunity/immunology , Glutamic Acid/physiology , Immunity, Innate/immunology , Organophosphate Poisoning/immunology , Organophosphates/toxicity , Adaptive Immunity/drug effects , Animals , Central Nervous System Diseases/chemically induced , Central Nervous System Diseases/drug therapy , Central Nervous System Diseases/immunology , Humans , Immunity, Innate/drug effects , Immunologic Factors/pharmacology , Immunologic Factors/therapeutic use , Organophosphate Poisoning/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...